Cargando…
The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer
BACKGROUND: There is a long-time unmet need for a means to detect breast cancer (BC) using blood. Although mammography is accepted as the gold standard for screening, a blood-based diagnostic can complement mammography and assist in the accurate detection of BC in the diagnostic process period of ea...
Autores principales: | Lee, Youn Ju, Kim, Young, Choi, Bo Bae, Kim, Je Ryong, Ko, Hye Mi, Suh, Kyoung Hoon, Lee, Jin Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722095/ https://www.ncbi.nlm.nih.gov/pubmed/34979986 http://dx.doi.org/10.1186/s12885-021-09055-1 |
Ejemplares similares
-
Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma
por: Cha, Mee-Kyung, et al.
Publicado: (2009) -
Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer
por: Chung, Jee Min, et al.
Publicado: (2018) -
The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein
por: Hwang, Jungwon, et al.
Publicado: (2014) -
The current status of cancer survivorship care and a consideration of appropriate care model in Korea
por: Ko, Hye Mi, et al.
Publicado: (2020) -
Erratum to: The current status of cancer survivorship care and a consideration of appropriate care model in Korea
por: Ko, Hye Mi, et al.
Publicado: (2021)